Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,686 | 148,851 | 87,490 | 85,875 | 90,642 |
| Receivables | 3,803 | 5,821 | 3,843 | 3,512 | 3,972 |
| Other current assets | 2,640 | 2,237 | 2,176 | 2,455 | 2,256 |
| TOTAL | $144,129 | $156,909 | $93,509 | $91,842 | $96,870 |
| Non-Current Assets | |||||
| PPE Net | 3,944 | 3,977 | 4,139 | 3,905 | 4,122 |
| Intangibles | 19,740 | 19,967 | 43,337 | 43,390 | 43,443 |
| Other Non-Current Assets | 1,684 | 1,529 | 1,526 | 1,524 | 1,522 |
| TOTAL | $25,368 | $25,473 | $49,002 | $48,819 | $49,087 |
| Total Assets | $169,497 | $182,382 | $142,511 | $140,661 | $145,957 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,419 | 8,216 | 4,766 | 4,735 | 2,445 |
| Accounts payable and accrued liabilities | 444 | 629 | 548 | 1,596 | 3,359 |
| Accrued Expenses | 10,533 | 7,650 | 9,437 | 7,920 | 9,555 |
| Other current liabilities | 7,050 | N/A | N/A | N/A | N/A |
| TOTAL | $23,446 | $16,495 | $14,751 | $14,251 | $15,359 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,180 | 38,332 | 42,878 | 45,015 | 47,242 |
| Other Non-Current Liabilities | 5,768 | 12,646 | 20,573 | 19,201 | 18,328 |
| TOTAL | $44,976 | $51,004 | $64,931 | $65,791 | $67,145 |
| Total Liabilities | $68,422 | $67,499 | $79,682 | $80,042 | $82,504 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,543 | 84,543 | 75,359 | 73,719 | 72,662 |
| Common Shares | 110 | 110 | 97 | 95 | 93 |
| Retained earnings | -609,208 | -594,504 | -570,147 | -554,975 | -541,586 |
| Other shareholders' equity | 154 | 166 | 170 | -542 | -1,883 |
| TOTAL | $101,075 | $114,883 | $62,829 | $60,619 | $63,453 |
| Total Liabilities And Equity | $169,497 | $182,382 | $142,511 | $140,661 | $145,957 |